Mirion Technologies (NYSE:MIR) Upgraded at B. Riley

Mirion Technologies (NYSE:MIR) was upgraded by stock analysts at B. Riley to a “strong-buy” rating in a research report issued on Wednesday, Zacks.com reports.

Mirion Technologies Stock Up 3.3 %

NYSE:MIR opened at $11.03 on Wednesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.18 and a quick ratio of 1.55. Mirion Technologies has a 1-year low of $6.70 and a 1-year high of $11.78. The company has a 50-day moving average of $10.40 and a 200 day moving average of $10.59. The firm has a market cap of $2.56 billion, a PE ratio of -26.89 and a beta of 0.79.

Mirion Technologies (NYSE:MIR) last announced its quarterly earnings results on Thursday, August 1st. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.03. The firm had revenue of $207.10 million during the quarter, compared to analysts’ expectations of $210.77 million. Mirion Technologies had a negative net margin of 7.80% and a positive return on equity of 3.81%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.08 EPS.

Insider Buying and Selling at Mirion Technologies

In other news, CEO Thomas D. Logan sold 7,500 shares of Mirion Technologies stock in a transaction that occurred on Wednesday, July 24th. The shares were sold at an average price of $10.87, for a total value of $81,525.00. Following the transaction, the chief executive officer now owns 1,544,017 shares of the company’s stock, valued at approximately $16,783,464.79. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Emmanuelle Lee sold 5,000 shares of the company’s stock in a transaction dated Wednesday, July 24th. The stock was sold at an average price of $10.80, for a total transaction of $54,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Thomas D. Logan sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, July 24th. The stock was sold at an average price of $10.87, for a total value of $81,525.00. Following the completion of the sale, the chief executive officer now directly owns 1,544,017 shares of the company’s stock, valued at approximately $16,783,464.79. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 54,639 shares of company stock valued at $568,947. 2.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Mirion Technologies

Hedge funds and other institutional investors have recently modified their holdings of the stock. Swedbank AB purchased a new stake in Mirion Technologies during the 1st quarter worth approximately $122,546,000. American Century Companies Inc. lifted its stake in shares of Mirion Technologies by 61.9% during the second quarter. American Century Companies Inc. now owns 3,942,571 shares of the company’s stock worth $42,343,000 after buying an additional 1,507,101 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Mirion Technologies by 40.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,738,900 shares of the company’s stock worth $38,325,000 after buying an additional 1,071,810 shares during the period. Nomura Holdings Inc. grew its holdings in shares of Mirion Technologies by 11.2% during the fourth quarter. Nomura Holdings Inc. now owns 4,916,574 shares of the company’s stock valued at $50,395,000 after buying an additional 493,939 shares during the last quarter. Finally, Nicholas Investment Partners LP acquired a new position in shares of Mirion Technologies in the 2nd quarter valued at $5,223,000. 78.51% of the stock is owned by hedge funds and other institutional investors.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.